LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Expenditure | ₹377 Cr | ₹337 Cr | ₹321 Cr | ₹299 Cr | ₹30,829,810 Cr |
What is the latest Total Expenditure of LINCOLN PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2023 | ₹377 Cr |
Mar2022 | ₹337 Cr |
Mar2021 | ₹321 Cr |
Mar2020 | ₹299 Cr |
Mar2019 | ₹30,829,810 Cr |
How is Total Expenditure of LINCOLN PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2023 | ₹377 Cr | 11.76 | |
Mar2022 | ₹337 Cr | 5.00 | |
Mar2021 | ₹321 Cr | 7.37 | |
Mar2020 | ₹299 Cr | -100.00 | |
Mar2019 | ₹30,829,810 Cr | - |
Compare Total Expenditure of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,192.7 Cr | -0.5% | 1.9% | 54.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.5% |
1.9% |
54.1% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses